Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for autoimmune diseases and cancer.
Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for autoimmune diseases and cancer.
Global Leadership
Advanced therapeutic development, sterile formulation, and quality assurance.
Register to manage your profile, publish articles to our readers, list your product catalogue and post jobs — all from one dashboard.